Novel Life Science Reagents
| Product Name | CAS No. | Specification | Application | Registration |
| Nemorubicin | 108852-90-0 | 98+% | antitumor activity | |
| Resmetirom | 920509-32-6 | 98+% | Thyroid Hormone Receptor | |
| Pirarubicin | 72496-41-4 | 98+% | Topoisomerase | Antibacterial | Antibiotic | Autophagy | |
| Valrubicin | 56124-62-0 | 98+% | PKC inhibitor | |
| Iclepertin | 1421936-85-7 | 98+% | GlyT inhibitor | |
| Pyrintegrin | 1228445-38-2 | 98+% | Integrin agonist | |
| 1-myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine | 273931-53-6 | 98+% | biochemical reagents | |
| Seco-DUBA hydrochloride | 1795733-93-5 | 95+% | ADC Cytotoxin | |
| 3-Deazaneplanocin A Hydrochloride | 120964-45-6 | 98+% | Histone Methyltransferase | Orthopoxvirus | |
| Ranibizumab | 347396-82-1 | 95+% | VEGFR | |
| Bevacizumab biosimilar | 216974-75-3 | 95+% | VEFG | |
| Z-LEVD-FMK | 1135688-25-3 | 98+% | ||
| Z-LEHD-FMK | 210345-04-3 | 98+% | ||
| Z-LETD-FMK(Ac-VAD-CHO;Ac-Val-Ala-Asp-CHO) | 147837-52-3 | 98+% | ||
| Z-VEID-FMK(Z-VE(OMe)ID(OMe)-FMK) | 210344-96-0 | 95+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn